Biolite, Inc.
Clinical trials sponsored by Biolite, Inc., explained in plain language.
-
New oral combo targets tough breast cancer in early trial
Disease control Not yet recruitingThis study tests an experimental oral liquid called BLEX 404 combined with the chemotherapy drug docetaxel in people with advanced triple negative breast cancer. The first part finds a safe dose, and the second part checks if the combination shrinks tumors. About 44 women aged 20…
Phase: PHASE1, PHASE2 • Sponsor: BioLite, Inc. • Aim: Disease control
Last updated May 09, 2026 04:35 UTC
-
New combo aims to cut infections in blood cancer patients
Disease control Not yet recruitingThis study tests a new oral liquid drug, BLEX 404, combined with a standard chemotherapy (azacitidine) in adults with certain types of blood cancers (MDS and CMML). The goal is to find a safe dose and see if it can reduce serious infections. About 52 people will take part in this…
Phase: PHASE2 • Sponsor: BioLite, Inc. • Aim: Disease control
Last updated May 07, 2026 18:43 UTC
-
New hope for cancer patients battling depression: experimental drug PDC-1421 enters early trials
Symptom relief Not yet recruitingThis early-phase study tests an experimental drug called PDC-1421 to see if it is safe and can help relieve depression in people with cancer. About 12 adults with stage I-III cancer and moderate to severe depression will take the drug for up to 5 weeks. Researchers will measure m…
Phase: PHASE1, PHASE2 • Sponsor: BioLite, Inc. • Aim: Symptom relief
Last updated May 08, 2026 12:02 UTC